Diagnosing Drug Allergy: the T is the Key
ConditionAmoxicillin Allergy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6+
SponsorUniversity Hospital, Antwerp
About this trial
The goal of this clinical trial is to validate a newly developed test in the diagnosis of patients with amoxicillin allergy (i.e. T-cell activation test). The main questions the study aims to assess are the reliability and applicability of this test. Participants will be asked to visit the hospital 1, 3 or 5 times during which blood is collected and when applicable, allergy skin testing is performed.
Eligibility criteria
Qualifiers
Are ≥ 6 years
Are capable of informed consent, or if appropriate, participants have an acceptable individual capable of giving consent on the participant's behalf (e.g. parent or guardian of a child under 18 years of age)
Have a suspected history of amoxicillin allergy
Disqualifiers
Patients who are lacking capacity or do not have an acceptable individual capable to provide informed consent
Pregnant women
Breastfeeding women
Trial design
Treatments tested in this trial
- T-cell activation test using intracellular markers
Treatment groups
300 Participants
are divided into 1 treatment groupSponsors and collaborators
University Hospital, Antwerp
Lead sponsor
AZ Jan Palfijn Gent
Collaborator
Universiteit Antwerpen
Collaborator
Source ClinicalTrials.gov